Mr. Michael J. Farrell, also known as Mick, BE, SM, MBA has been the Chief Executive Officer of ResMed Inc. since March 1, 2013. Mr. Farrell served as President of Americas Operations at ResMed Inc. since May 2011. Mr. Farrell served as Senior Vice President of Strategic Business Unit - Patient Interfaces at ResMed Inc., since July 2007. He served as Vice President, Marketing for the Americas at ResMed from June 2005 to 2007, he was Vice President of Business Development, leading acquisitions and strategic alliances as well as the establishment of a new market development team. Mr. Farrell joined ResMed in September 2000 and he worked in management consulting and biotechnology, as well as in chemicals and steel manufacturing at Arthur D. Little, Genzyme Corporation, The Dow Chemical Company, Vale and BHP Billiton. He has been a Director of ResMed Inc. since March 1, 2013. He has been an Independent Director of Zimmer Biomet Holdings, Inc. since December 11, 2014. Mr. Farrell holds a Bachelor of Engineering, with first-class honors, from the University of New South Wales, a Master of Science in Chemical Engineering from the Massachusetts Institute of Technology and an M.B.A. from the MIT Sloan School of Management.      

 orthopedics